Wedbush Maintains Bullish Outlook on Cerebras Ahead of Q1

Wedbush maintained its "Outperform" rating and $270 price target on Cerebras Systems (NASDAQ: CBRS) on June 22, ahead of the company's Q1 2026 earnings release scheduled for June 23. Per Seeking Alpha, Wedbush characterized the setup as "expecting any inflections will be positive." The firm's key upside drivers: execution against backlog, incremental wafer output from TSMC manufacturing optimization, favorable AI accelerator market dynamics, and performance upgrades to existing products.

Cerebras uses on-chip SRAM rather than HBM (high-bandwidth memory) in its Wafer-Scale Engine architecture. Wedbush notes this shifts supply vulnerability away from HBM memory market constraints - a recurring bottleneck for competing accelerator vendors - while concentrating risk on wafer-scale yield and foundry throughput instead. The third-generation WSE-3 integrates 4 trillion transistors and 44GB of on-chip SRAM, enabling fast token generation for inference workloads without off-chip memory transfers.

Wedbush flags a speculative next-generation WSE-4 product as a potential catalyst for margin expansion and revenue growth - but explicitly excludes it from current forward numbers. Any formal announcement or technical disclosure around WSE-4 would represent incremental upside to current estimates.

Cerebras has received broadly bullish initial coverage: Craig-Hallum (Buy, $325), Needham (Buy, $300), Rosenblatt (Buy, $300), Mizuho (Outperform, $300), and Wedbush (Outperform, $270) - the lowest target in the group. Per Investing.com, the stock trades at roughly $226.82 as of June 22, down 23.5% year-to-date despite 76% revenue growth over the past twelve months.

Q1 results (June 23 after market close) will be the first readout on shipment volumes, backlog, and commentary on TSMC manufacturing yields - the concrete supply-side variables Wedbush emphasized. Any formal WSE-4 announcement would also re-rate forward estimates.